LivaNova (NASDAQ:LIVN) Sets New 12-Month High - Here's What Happened

Key Points

• LivaNova PLC achieved a new 12-month high, with its stock price reaching $58.91 on Wednesday, up from a previous close of $58.32.
• Analysts have generally favored the stock, with Needham & Company issuing a "buy" rating and a price target of $64.00, while the consensus rating is currently "buy" with a target of $59.71.
• The company reported a quarterly EPS of $1.05, exceeding estimates by 21 cents, and saw a revenue increase of 10.6% year-over-year, totaling $352.5 million.

LivaNova PLC (NASDAQ:LIVN - Get Free Report)'s stock price reached a new 52-week high on Wednesday . The company traded as high as $58.91 and last traded at $58.72, with a volume of 388480 shares trading hands. The stock had previously closed at $58.32.

Analysts Set New Price Targets

A number of analysts have weighed in on LIVN shares. Needham & Company LLC restated a "buy" rating and set a $64.00 price objective on shares of LivaNova in a research note on Wednesday, September 3rd. Wall Street Zen upgraded shares of LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Barclays lifted their price target on shares of LivaNova from $55.00 to $58.00 and gave the stock an "equal weight" rating in a research note on Thursday, August 21st. Finally, Wolfe Research upgraded shares of LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price target for the company in a research note on Tuesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $59.71.

LivaNova Price Performance

The business's 50 day moving average price is $49.83 and its 200 day moving average price is $44.09. The stock has a market capitalization of $3.06 billion, a P/E ratio of -14.39 and a beta of 0.96. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.29 and a quick ratio of 1.09.

LivaNova (NASDAQ:LIVN - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $1.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.21. The company had revenue of $352.50 million for the quarter, compared to the consensus estimate of $332.20 million. LivaNova had a negative net margin of 16.13% and a positive return on equity of 14.57%. The firm's revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.93 earnings per share. Sell-side analysts forecast that LivaNova PLC will post 2.85 EPS for the current year.

Hedge Funds Weigh In On LivaNova

A number of institutional investors and hedge funds have recently made changes to their positions in LIVN. Primecap Management Co. CA lifted its holdings in LivaNova by 0.7% during the second quarter. Primecap Management Co. CA now owns 4,641,352 shares of the company's stock valued at $208,954,000 after purchasing an additional 32,942 shares in the last quarter. Vanguard Group Inc. lifted its holdings in LivaNova by 13.5% during the first quarter. Vanguard Group Inc. now owns 2,666,880 shares of the company's stock valued at $104,755,000 after purchasing an additional 316,993 shares in the last quarter. AQR Capital Management LLC lifted its holdings in LivaNova by 30.5% during the second quarter. AQR Capital Management LLC now owns 2,049,820 shares of the company's stock valued at $92,201,000 after purchasing an additional 478,525 shares in the last quarter. Geode Capital Management LLC lifted its holdings in LivaNova by 1.3% during the second quarter. Geode Capital Management LLC now owns 1,429,740 shares of the company's stock valued at $64,374,000 after purchasing an additional 18,551 shares in the last quarter. Finally, Artisan Partners Limited Partnership lifted its holdings in LivaNova by 112.9% during the second quarter. Artisan Partners Limited Partnership now owns 1,247,609 shares of the company's stock valued at $56,167,000 after purchasing an additional 661,480 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.